Eli Lilly investiert 50 Millionen US-Dollar in Absci für KI-gestützte Haarausfall-Therapien

Pharmaceutical giant Eli Lilly and Company has moved to expand its footprint in generative biology by leading a $50 million investment round in Absci Corporation, a company specializing in artificial intelligence-driven drug discovery. The funding, which includes $40 million in equity, aims to accelerate the development of novel protein-based therapeutics, with early applications reportedly targeting … Read more

Ještě účinější než Ozempic. Zázračný lék nové generace je průlomový, funguje odlišně – E15.cz

The landscape of weight-loss pharmacology is shifting rapidly as pharmaceutical companies push the boundaries of metabolic medicine. Recent clinical data regarding the experimental drug retatrutide have captured the attention of the medical community, suggesting a potential step forward in the treatment of obesity. As researchers continue to evaluate the efficacy and safety of this new … Read more

Eli Lilly Stock: Optimism Soars on Market Momentum

Eli Lilly invests $2.7 Billion in North Carolina Manufacturing Facility Eli Lilly and Company will invest $2.7 billion too build a new manufacturing facility in research Triangle Park, North Carolina, considerably expanding its production capacity. Pennsylvania Governor Josh Shapiro announced the commitment after the site prevailed over more than 300 applicants. key factors in the … Read more